Results 31 to 40 of about 114,754,979 (236)

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis

Urology Research and Practice, 2023
Objective: This study aimed to evaluate retrospectively the outcomes of Abobotulinumtoxin-A (Dysport®) intravesical injection in refractory interstitial cystitis/ bladder pain syndrome patients to first- and second-line treatment.
Mohammad-Sajjad Rahnamai, Hanieh Salehi-Pourmehr, Sana Saeedi, Sona Tayebi, Sakineh Hajebrahimi   +4 more
doaj   +1 more source

The positive effect of Botulinum toxin type A on the viability of random flap in tobacco exposed in rats [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE: To evaluate the effect of Botulinum Toxin A in different time of tobacco exposure. METHODS: 60 male, Wistar rats were divided into two tobacco exposure groups: a 2- month or a 4-month regimen.
Cristina Pires Camargo, Felipe Alexandre Fernandes, Michel Hyo Mi Lee, Luiza Campos Moreira Silva, Julio Morais Besteiro, Rolf Gemperli   +5 more
doaj   +2 more sources

Treatment of periorbital syringoma with intradermal botulinum toxin A monotherapy versus carbon dioxide laser: a case report [PDF]

Surgical & Cosmetic Dermatology
Syringomas are benign adnexal neoplasms that develop from eccrine sweat ducts. They are mostly found in early adulthood, with a female gender predominance. They typically occur on the face, particularly the periorbital region, which has a high demand for
Sheila Hustadi Budiawan, Abraham Arimuko, Lilik Norawati, Asnawi Madjid, Widya Widita   +4 more
doaj   +1 more source

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]

, 2010
Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Mayer, Margit E., Yasmin Hocaoglu, Alexander Buchner, Hocaoglu, Yasmin, Buchner, Alexander, Christian G. Stief, Bauer, Ricarda M., Alexander Roosen, Stief, Christian G., May, Florian, Christian Gratzke, Ricarda M. Bauer, Margit E. Mayer, Gratzke, Christian, Florian May, Roosen, Alexander   +15 more
core   +1 more source

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

Arquivos de Neuro-Psiquiatria
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva   +4 more
doaj   +1 more source

High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections

Toxins, 2022
Improvements in Botulinum toxin type-A (BoNT-A) aesthetic treatments have been jeopardized by the simplistic statement: “BoNT-A treats wrinkles”. BoNT-A monotherapy relating to wrinkles is, at least, questionable.
Alexander D. Nassif, Ricardo F. Boggio, Sheila Espicalsky, Gladstone E. L. Faria   +3 more
doaj   +1 more source

Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update

Toxins
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho, Moises Dominguez, Christopher L. Robinson, Sait Ashina   +3 more
doaj   +1 more source

Botulinum Toxin A for the Treatment of Keloids [PDF]

, 2012
Introduction: Keloids are the result of excessive scar tissue formation. Besides their poor aesthetic appearance, keloids can be associated with severe clinical symptoms such as pain, itching, and rigidity.
Bureik, D., Schauber, J, Ruzicka, T, Gauglitz, Gerd, Dombrowski, Yvonne, Pavicic, T., Pavicic, T, Ruzicka, Thomas, Gauglitz, G G, Schauber, Jürgen, Dombrowski, Y; id_orcid, Bureik, D   +11 more
core   +1 more source

Genetically Confirmed Schwartz–Jampel Syndrome: An Ultra-Rare Case of Congenital Myotonia with Osteochondrodysplasia from India

International Journal of Medical Students
Background: Schwartz–Jampel syndrome is a rare autosomal recessive disorder caused by mutations in the HSPG2 gene, leading to perlecan deficiency. Perlecan is a heparan sulfate proteoglycan critical for cartilage integrity, basement membrane stability ...
Nandita Jali, Suvarna Magar, Tanya Trikha, Varsha Vaidya, Viranchi Vaidya   +4 more
doaj   +1 more source

Personality Disorders among Individuals Seeking Cosmetic Botulinum Toxin Type A (BoNTA) Injection, a Cross-Sectional Study

Eurasian Journal of Medicine, 2019
Objective: Body dysmorphic disorder, narcissistic personality disorder, and histrionic personality disorders are the most frequent personality disorders in patients seeking cosmetic interventions.
Alireza Mohebbipour Loron, Azra Ghaffari, Negin Poursafargholi   +2 more
doaj   +1 more source